How to buy Cue Health stock (Cue Health)

Cue Health, maker of COVID-19 tests, completed its initial public offering at $16 per share, right in the middle of its pricing expectations. The IPO raised $200 million for the company and gives it a valuation of $2.3 billion.

HLTH will debut on the Nasdaq later today, but shares are available for limit orders on Robinhood and other platforms.

Our top picks for where to buy Cue Health stock

Buy Cue Health stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Cue Health stock price (NASDAQ: HLTH)

Use our graph to track the performance of HLTH stocks over time.

Cue Health shares at a glance

• Key figures

Information last updated 2024-08-11.

52-week range	$0.00 - $0.35
50-day moving average more info button	$0.11
200-day moving average more info button	$0.25
Wall St. target price	$0.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-2.13

Is it a good time to buy Cue Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cue Health financials

Revenue TTM	$56.2 million
Gross profit TTM	$-17,949,000
Return on assets TTM	-30.8%
Return on equity TTM	-94.57%
Profit margin	0%
Book value	$1.26
Market Capitalization more info button	$6.9 million

TTM: trailing 12 months

Cue Health share dividends

We're not expecting Cue Health to pay a dividend over the next 12 months.

You may also wish to consider:

• Quest Diagnostics Incorporated (DGX.US) (1.98% forward annual dividend yield)

Cue Health share price volatility

Over the last 12 months, Cue Health's shares have ranged in value from as little as $0.0036 up to $0.35. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cue Health's is 1.086. This would suggest that Cue Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put Cue Health's beta into context you can compare it against those of similar companies.

• Co-Diagnostics (CODX.US): -0.846
• Quest Diagnostics Incorporated (DGX.US): 0.891
• Hologic (HOLX.US): 0.986

Cue Health overview

Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017.

Frequently asked questions

null
What percentage of Cue Health is owned by insiders or institutions?
Currently 11.565% of Cue Health shares are held by insiders and 52.807% by institutions. How many people work for Cue Health?
Latest data suggests 726 work at Cue Health. When does the fiscal year end for Cue Health?
Cue Health's fiscal year ends in December. Where is Cue Health based?
Cue Health's address is: 4980 Carroll Canyon Road, San Diego, CA, United States, 92121 What is Cue Health's ISIN number?
Cue Health's international securities identification number is: US2297901009